Inside Back Cover - Editors with images
(Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology)
Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology - May 17, 2024 Category: OBGYN Source Type: research

Dimensional versus standard 2-D laparoscopy for benign hysterectomy: A randomized clinical trial
Our aim was to evaluate possible short and long-term benefits of 3-dimensional (3-D) compared to 2-dimensional (2-D) laparoscopy for benign hysterectomy.Primary outcomes were long-term quality of life and postoperative pain. Secondary outcomes were operative time, surgical complications, time to return to work and length of hospitalization. (Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology)
Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology - May 17, 2024 Category: OBGYN Authors: Giorgia Roman ò, Niels Klarskov, Pernille Danneskiold Lassen, Gitte Bennich, Elise Hoffmann Tags: Full length article Source Type: research

Comparison of single- and double-dose methotrexate protocols for treatment of pregnancy of unknown location
Pregnancy of unknown location (PUL) is defined as the presence of a positive pregnancy test without confirmation by transvaginal ultrasound of either intrauterine pregnancy or ectopic pregnancy (EP) [1]. The incidence of PUL is not well described, and a final diagnosis of either intrauterine pregnancy, early pregnancy loss or EP is obtained in 30 –50 % of cases, meaning that the location is never confirmed in 50–70 % of patients with PUL. (Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology)
Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology - May 16, 2024 Category: OBGYN Authors: Magdalena M. Pir óg, Anna Pulka, Przemysław Urbaniec, Robert Jach Tags: Full length article Source Type: research

Gestational weight gain: Toward best practices in managing gestational weight gain in patients with obesity: Comparison of recommendations
Obesity is the disease of the 21st century; it affects every age group and can cause a variety of illnesses considered severe public health problems. There is now a true obesity epidemic in developed countries, prompting the World Health Organization to characterize the situation as a significant threat to health. In 2016, there were more than 1.9 billion overweight adults (over age 18) worldwide. Of that total, 650 million were obese. The global prevalence of obesity nearly tripled from 1975 to 2016 [1]. (Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology)
Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology - May 15, 2024 Category: OBGYN Authors: Sebastien Grandfils, Pauline Durand, Hoge Axelle, Seidel Laurence, Patrick Emonts, Nicolas Paquot, Jean Christophe Philips Tags: Full length article Source Type: research

Breast cancer awareness among women of reproductive age- a questionnaire based study
Cancer is the growth of abnormal cells in any bodily organ, and breast cancer is one of them. Breast cancer is the most common type of cancer among women in both developed and developing countries. The incidence and mortality are growing at a faster rate. It can occur in several types, and it progresses through different stages involving more organs before spreading. It is extremely difficult to manage cancer if presented at advanced stages, which is a very common feature of breast cancer patients, especially in low- and middle-income countries. (Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology)
Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology - May 14, 2024 Category: OBGYN Authors: Saswati Tripathy, Satyajit Mohapatra, A. Preethika Tags: Full length article Source Type: research

Stage II endometrial cancer: The diagnostic power of hysteroscopic excisional biopsy and MRI in the pre-operative cervical stroma assessment
Endometrial cancer (EC) is the most common gynaecological malignancy in western countries [1]. EC is mainly discovered in an early stage (stage I or II) due to early symptoms such as irregular vaginal bleeding [2]. Secondarily to a histological endorsement, preoperative work-up must include family, general and gynaecological history, pelvic examination, transvaginal or transrectal ultrasound (US), Magnetic resonance imaging (MRI) and computed tomography scan (CT) [3]. (Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology)
Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology - May 13, 2024 Category: OBGYN Authors: Fabio Francesco Ciancio, Giulio Insalaco, Simone Millan, Claudia Randazzo, Federica Grasso, Giuseppina Trombetta, Marianna Gulisano, Maria Teresa Bruno, Gaetano Valenti Tags: Full length article Source Type: research

Discriminative diagnosis of ovarian endometriosis cysts and benign mucinous cystadenomas based on the ConvNeXt algorithm
The objective of this study was to develop a deep learning model, using the ConvNeXt algorithm, that can effectively differentiate between ovarian endometriosis cysts (OEC) and benign mucinous cystadenomas (MC) by analyzing ultrasound images. The performance of the model in the diagnostic differentiation of these two conditions was also evaluated. (Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology)
Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology - May 13, 2024 Category: OBGYN Authors: Kuo Miao, Qian Lv, Liwei Zhang, Ning Zhao, Xiaoqiu Dong Tags: Full length article Source Type: research

Pregnancy with endometriosis: Assessment of national-level trends, characteristics, and maternal morbidity at delivery
Endometriosis is a gynecologic condition defined by the implantation of endometrial tissue outside of the uterus [1]. This disease affects approximately 10  % of reproductive aged women and is characterized by chronic pain and subfertility [1]. Different classifications systems exist to describe the severity of endometriosis, most recently with a focus on surgical complexity. However, it has been shown that the calculated stage of endometriosis often does not correlate with symptomology [2–4]. (Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology)
Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology - May 13, 2024 Category: OBGYN Authors: Caroline J. Violette, Laurel S. Aberle, Zachary S. Anderson, Emi J. Komatsu, Bonnie B. Song, Rachel S. Mandelbaum, Shinya Matsuzaki, Joseph G. Ouzounian, Koji Matsuo Tags: Full length article Source Type: research

Abnormal maternal apolipoprotein levels during pregnancy are risk factors for preterm birth in women with dichorionic twin pregnancies: A retrospective study
Due to the rapid development of assisted reproductive technology, the incidence of twin pregnancies has increased dramatically in the past few decades [1,2]. The incidence of twin pregnancies in the United States was 32.6 per 1000 pregnancies in 2018[3]. Twin-pregnant women have 10 times the risk of preterm birth and 5 times the risk of serious complications compared with singleton-pregnant women [4]. The health needs of preterm infants are a heavy burden for families and society, and reducing the preterm birth rate has become a major public health issue [5]. (Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology)
Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology - May 13, 2024 Category: OBGYN Authors: Pingping Su, Yao Su, Xinrui Jia, Huan Han, Wenjiao Li, Hao Ying Tags: Full length article Source Type: research

Aggressive angiomyxoma of female pelvis and perineum: Retrospective study of 17 cases
Aggressive angiomyxoma (AAM) is a rare mesenchymal myxoid neoplasm originating from soft tissues in the pelvic region, such as perineum and vaginal wall [1]. It predominantly affects women of reproductive age, while occurring less frequently in men, with a male to female ratio of 1:6 [2 –5]. In 1983, Steeper and Rosai first reported nine cases of AAM [6], primarily focusing on its pathological characteristics. (Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology)
Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology - May 12, 2024 Category: OBGYN Authors: Hong Qu, Na Liu, Huamao Liang, Ying Wang, Huiyu Zhuang, Hua Li Tags: Full length article Source Type: research

The genetics and clinical outcomes in 151 cases of fetal growth restriction: A Chinese single-center study
The Delphi procedure defines fetal growth restriction (FGR) based on gestational age, abdominal circumference, weight, umbilical artery end-diastolic blood flow, uterine artery pulsatility index, and cerebroplacental ratio, and classifies it into early and late-onset FGR [1]. The Royal College of Obstetricians and Gynaecologists, Society of Gynecologists of Canada (SOGC), and Chinese expert consensus on FGR (2019) define FGR as fetal growth failure to reach its genetic potential due to the influence of maternal, fetal, placental and other pathological factors. (Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology)
Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology - May 11, 2024 Category: OBGYN Authors: Can Peng, LanPing Hu, XiuFen Bu, HongYu Li, XuanYu Jiang, ShiHao Zhou, Li Deng, Jun He, SiYuan LinPeng Tags: Full length article Source Type: research

Data integrity of 14 randomised controlled trials
A review of the literature of iron treatments for iron-deficient anaemia in pregnancy indicated integrity problems in two randomised controlled trials (RCTs) from the author Dr A.M. Darwish, Assiut University, Egypt (Dawish 2017, Darwish 2019a0 [1]. There were worrying similarities between the tables of papers that purport to present the results of distinct studies. We therefore assessed all the papers of this author, following methods as previously described [2]. (Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology)
Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology - May 10, 2024 Category: OBGYN Authors: Ben W. Mol, Esmee M. Bordewijk, Ewelina Rogozi ńska, Lyle C. Gurrin, Jim G. Thornton, Madelon van Wely Tags: Full length article Source Type: research

Relationship between hypertensive disorders of pregnancy (HDP) and cardiac remodeling during pregnancy: Systematic review and meta-analysis
Hypertensive disorders of pregnancy (HDP) affect up to 6 –8 % of all pregnancies. It is one of the three leading causes of maternal mortality and morbidity worldwide [1]. Existing studies have consistently shown increased risk for cardiovascular disease (CVD) in women with known history of HDP [2–4]. Though there is significant number of studies tha t support the long-term effect of CVD after HDP [5], there is insufficient evidence supporting HDP related CVD during pregnancy. (Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology)
Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology - May 8, 2024 Category: OBGYN Authors: Philip Eghan, Aba A Folson, Andrew Donkor, Collins Kokuro, Yaw Amo Wiafe Tags: Review article Source Type: research

Fetal agenesis of the corpus callosum: Clinical and genetic analysis in a series of 40 patients
This study aimed to explore the genetic causes of agenesis of the corpus callosum (ACC) and assess the utility of karyotype analysis, copy number variation sequencing (CNV-seq), and whole-exome sequencing (WES) to genetically diagnose fetal ACC. (Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology)
Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology - May 8, 2024 Category: OBGYN Authors: Hengqing Sun, Ke Li, Lu Wang, Lijuan Zhao, Chenyu Yan, Xiangdong Kong, Ning Liu Tags: Full length article Source Type: research

Postmenopausal hormone therapy and cognition in twins
Basic science has hypothesised that oestrogen may have a neuroprotective function with a modulating effect on neurotransmitters throughout the brain [1,2,3]. Thus, hormone therapy (HT) consisting of oestrogen alone or combined with a progestogen which can be used during menopause as a way to relieve menopausal symptoms could potentially influencing cognitive function (Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology)
Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology - May 8, 2024 Category: OBGYN Authors: Laura L. Johansen, Kaare Christensen, Jesper Hallas, Merete Osler, Mikael Thinggaard Tags: Full length article Source Type: research